Free Trial

Kooth (KOO) Competitors

Kooth logo
GBX 160 +2.00 (+1.27%)
As of 11:47 AM Eastern

KOO vs. INS, RENX, COG, INHC, FDBK, TRLS, IQAI, DVRG, SENS, and EMIS

Should you be buying Kooth stock or one of its competitors? The main competitors of Kooth include Instem (INS), Renalytix (RENX), Cambridge Cognition (COG), Induction Healthcare Group (INHC), Feedback (FDBK), Trellus Health (TRLS), IQ-AI (IQAI), DeepVerge (DVRG), Sensyne Health (SENS), and EMIS Group (EMIS). These companies are all part of the "health information services" industry.

Kooth vs.

Kooth (LON:KOO) and Instem (LON:INS) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, media sentiment, profitability, institutional ownership, community ranking, analyst recommendations and risk.

In the previous week, Instem had 1 more articles in the media than Kooth. MarketBeat recorded 1 mentions for Instem and 0 mentions for Kooth. Instem's average media sentiment score of 1.60 beat Kooth's score of 0.00 indicating that Instem is being referred to more favorably in the news media.

Company Overall Sentiment
Kooth Neutral
Instem Very Positive

Kooth has higher earnings, but lower revenue than Instem. Instem is trading at a lower price-to-earnings ratio than Kooth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kooth£50.72M1.16£4.00M£10.6415.03
Instem£61.63M0.00£3.34M£0.14N/A

Kooth has a beta of 0.71, meaning that its stock price is 29% less volatile than the S&P 500. Comparatively, Instem has a beta of 0.42, meaning that its stock price is 58% less volatile than the S&P 500.

65.0% of Kooth shares are owned by institutional investors. Comparatively, 65.9% of Instem shares are owned by institutional investors. 17.3% of Kooth shares are owned by company insiders. Comparatively, 30.0% of Instem shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Instem received 79 more outperform votes than Kooth when rated by MarketBeat users. However, 93.33% of users gave Kooth an outperform vote while only 52.25% of users gave Instem an outperform vote.

CompanyUnderperformOutperform
KoothOutperform Votes
14
93.33%
Underperform Votes
1
6.67%
InstemOutperform Votes
93
52.25%
Underperform Votes
85
47.75%

Kooth has a net margin of 7.89% compared to Instem's net margin of 5.50%. Kooth's return on equity of 18.59% beat Instem's return on equity.

Company Net Margins Return on Equity Return on Assets
Kooth7.89% 18.59% 10.12%
Instem 5.50%6.35%4.62%

Kooth presently has a consensus target price of GBX 456.67, suggesting a potential upside of 185.42%. Given Kooth's stronger consensus rating and higher possible upside, equities research analysts clearly believe Kooth is more favorable than Instem.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Kooth
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
Instem
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

Kooth beats Instem on 10 of the 17 factors compared between the two stocks.

Get Kooth News Delivered to You Automatically

Sign up to receive the latest news and ratings for KOO and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

KOO vs. The Competition

MetricKoothHealth Information Services IndustryMedical SectorLON Exchange
Market Cap£58.72M£211.57M£5.33B£2.66B
Dividend YieldN/A6.68%5.21%5.05%
P/E Ratio15.03328.9326.85129.21
Price / Sales1.16432.39388.74221,406.02
Price / Cash5.4247.1438.2528.02
Price / Book2.485.356.763.79
Net Income£4.00M-£15.55M£3.23B£5.88B
7 Day Performance19.58%0.45%1.71%0.63%
1 Month Performance6.28%7.42%11.16%22.11%
1 Year Performance-47.37%6.24%17.17%120.87%

Kooth Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KOO
Kooth
N/AGBX 160
+1.3%
GBX 456.67
+185.4%
-48.0%£58.72M£50.72M15.03478
INS
Instem
N/AN/AN/AN/A£199.62M£61.63M5,928.57500Positive News
RENX
Renalytix
N/AGBX 8.01
-2.9%
N/A-62.8%£33.20M£9.22M-0.38102
COG
Cambridge Cognition
N/AGBX 36.36
-3.0%
N/A-14.2%£15.22M£15.64M-9.6680
INHC
Induction Healthcare Group
N/AGBX 9.60
+1.1%
N/A-23.2%£8.86M£12.57M-1.7374
FDBK
Feedback
N/AGBX 13.74
-0.1%
N/A-80.6%£6.02M£3.88M-0.5624
TRLS
Trellus Health
N/AGBX 1.72
-7.0%
N/A+24.6%£3.33M£65,831.01-0.5031Gap Down
IQAI
IQ-AI
N/AGBX 0.80
-3.0%
N/A-39.3%£1.77M£538,190.00-13.676News Coverage
DVRG
DeepVerge
N/AN/AN/AN/A£1.14M£12.41M-15.0073
SENS
Sensyne Health
N/AN/AN/AN/A£583,000.00£7.81M-0.0270Gap Down
EMIS
EMIS Group
N/AN/AN/AN/A£1.23B£176.86M4,085.111,560News Coverage

Related Companies and Tools


This page (LON:KOO) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners